ÐÇ¿Õ´«Ã½

Skip to main content

What other health conditions are weight-loss drugs being tested for?

The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File) The injectable drug Ozempic is shown Saturday, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File)
Share

Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival medicines Ozempic and Wegovy, are being studied to see whether they can improve health in other ways.

The U.S. Food and Drug Administration on Friday  Novo's Wegovy for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes.

Below are other conditions obesity treatments are being tested against:

Alcohol addiction

A study by the University of Copenhagen's Psychiatric Centre Rigshospitalet is investigating whether semaglutide, sold as Novo's Wegovy and Ozempic, can help reduce alcohol intake in  diagnosed with alcohol use disorder and obesity.

Alzheimer's disease

Novo Nordisk has begun a  testing semaglutide in patients with early Alzheimer's disease. The study, which will enrol 1,840 patients, could reach primary completion as early as 2025.

Cardiovascular disease

Eli Lilly is testing tirzepatide, sold as Mounjaro and Zepbound, for patients  and obesity. Lilly plans to enrol about 700 people in the study, which is expected to be completed by July 2024.

Researchers at the Chinese University of Hong Kong are testing Novo's semaglutide along with the mechanical removal of clots in patients with strokes caused by the blockage of large blood vessels to the brain. The approach will be compared with standard therapy. The mid-stage  aims to recruit about 140 patients.

Chronic kidney disease

Novo's Ozempic delayed the progression of chronic kidney disease in diabetes patients, cutting the risk of death from that and major cardiac events by 24%. That was, however, below investor expectations.

Lilly's tirzepatide is being evaluated in a  of chronic kidney disease in patients with obesity. Lilly plans to enrol up to 140 participants.

Liver disease

Novo is testing semaglutide in a late-stage trial of patients with a common type of fatty liver disease called non-alcoholic steatohepatitis (NASH). The  is expected to enroll about 1,200 patients.

 helped up to 74% of patients achieve absence of the disease with no worsening of liver scarring at 52 weeks, compared with 13% of patients on placebo, in a mid-stage trial for the fatty liver disease formerly known as NASH and now called metabolic dysfunction-associated steatohepatitis, or MASH.

Neurological disorders

Researchers at the Danish Headache Centre are testing semaglutide along with a very low-calorie diet as a treatment for new-onset idiopathic intracranial hypertension, a condition associated with obesity in which blood pressure inside the head rises. The  aims to recruit about 50 patients and wrap up as early as 2025.

Sleep apnea

Lilly's tirzepatide is in  for patients with obstructive sleep apnea and obesity, including people who use respiratory devices that help keep their airways open while they sleep, as well as people who don't use such devices. The study is expected to enrol about 469 participants.

(Reporting by Patrick Wingrove in New York and Sriparna Roy in Bengaluru. Editing by Bill Berkrot and Devika Syamnath)

CTVNews.ca ÐÇ¿Õ´«Ã½

The province's public security minister said he was "shocked" Thursday amid reports that a body believed to be that of a 14-year-old boy was found this week near a Hells Angels hideout near Quebec City.

Shamattawa RCMP are searching for a missing six-year-old boy who hasn’t been seen since Wednesday morning.

B.C.'s police watchdog is investigating the death of a woman who was shot by the RCMP after allegedly barricading herself in a room with a toddler early Thursday morning.

Quebec Premier Francois Legault is calling on the Bloc Quebecois to topple the Trudeau government next Wednesday and trigger a federal election.

Local Spotlight

They say a dog is a man’s best friend. In the case of Darren Cropper, from Bonfield, Ont., his three-year-old Siberian husky and golden retriever mix named Bear literally saved his life.

Paleontologists from the Royal B.C. Museum have uncovered "a trove of extraordinary fossils" high in the mountains of northern B.C., the museum announced Thursday.

The search for a missing ancient 28-year-old chocolate donkey ended with a tragic discovery Wednesday.

The Royal Canadian Mounted Police is celebrating an important milestone in the organization's history: 50 years since the first women joined the force.

It's been a whirlwind of joyful events for a northern Ontario couple who just welcomed a baby into their family and won the $70 million Lotto Max jackpot last month.

A Good Samaritan in New Brunswick has replaced a man's stolen bottle cart so he can continue to collect cans and bottles in his Moncton neighbourhood.

David Krumholtz, known for roles like Bernard the Elf in The Santa Clause and physicist Isidor Rabi in Oppenheimer, has spent the latter part of his summer filming horror flick Altar in Winnipeg. He says Winnipeg is the most movie-savvy town he's ever been in.

Edmontonians can count themselves lucky to ever see one tiger salamander, let alone the thousands one local woman says recently descended on her childhood home.

A daytrip to the backcountry turned into a frightening experience for a Vancouver couple this weekend.